A Maryland bank agreed to pay about $22.9 million to settle charges by two U.S. regulators that it failed to disclose tens of millions of dollars of loans to family trusts belonging to its former longtime chief executive officer.
DOJ Short Seller Probe Fails To Silence Activists institutionalinvestor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from institutionalinvestor.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
NEW ORLEANS, April 16, 2021 /PRNewswire/ Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ( KSF ), announces that KSF has commenced an investigation into Vanda Pharmaceuticals Inc. (NasdaqGM: VNDA).
On February 11, 2019, Aurelius Value reported that the Company was involved in an off-label promotion scheme in which its drug products, Fanapt and Hetlioz, were marketed to treat disorders for which the drugs were not FDA-approved, for example, promoting sales of Fanapt to children with schizophrenia, rather than adults, in a manner that was inconsistent with the FDA s authorization.